Repro Med Systems Stock Price Prediction
| KRMD Stock | USD 3.52 0.06 1.68% |
Oversold Vs Overbought
61
Oversold | Overbought |
Quarterly Earnings Growth (0.66) | EPS Estimate Next Quarter (0.04) | EPS Estimate Current Year (0.11) | EPS Estimate Next Year (0.08) | Wall Street Target Price 4.1 |
Using Repro Med hype-based prediction, you can estimate the value of Repro Med Systems from the perspective of Repro Med response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Repro Med to buy its stock at a price that has no basis in reality. In that case, they are not buying Repro because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Repro Med after-hype prediction price | USD 3.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Repro |
Repro Med After-Hype Price Prediction Density Analysis
As far as predicting the price of Repro Med at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Repro Med or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Repro Med, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Repro Med Estimiated After-Hype Price Volatility
In the context of predicting Repro Med's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Repro Med's historical news coverage. Repro Med's after-hype downside and upside margins for the prediction period are 0.10 and 7.06, respectively. We have considered Repro Med's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Repro Med is risky at this time. Analysis and calculation of next after-hype price of Repro Med Systems is based on 3 months time horizon.
Repro Med Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Repro Med is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Repro Med backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Repro Med, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.70 | 3.49 | 0.07 | 0.41 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.52 | 3.58 | 0.00 |
|
Repro Med Hype Timeline
Repro Med Systems is now traded for 3.52. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of 0.41. Repro is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 0.7%. %. The volatility of related hype on Repro Med is about 600.69%, with the expected price after the next announcement by competition of 3.93. About 54.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.26. Repro Med Systems had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Repro Med Basic Forecasting Models to cross-verify your projections.Repro Med Related Hype Analysis
Having access to credible news sources related to Repro Med's direct competition is more important than ever and may enhance your ability to predict Repro Med's future price movements. Getting to know how Repro Med's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Repro Med may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| POCI | Precision Optics, | (0.21) | 6 per month | 4.06 | (0.01) | 7.48 | (6.99) | 18.59 | |
| INFU | InfuSystems Holdings | 0.34 | 11 per month | 2.69 | 0.14 | 7.64 | (4.81) | 22.10 | |
| UTMD | Utah Medical Products | (0.90) | 8 per month | 0.00 | (0.15) | 1.17 | (1.82) | 7.07 | |
| MLSS | Milestone Scientific | (0.04) | 8 per month | 0.00 | (0.12) | 5.56 | (7.89) | 27.59 | |
| MMSI | Merit Medical Systems | 2.98 | 11 per month | 0.71 | 0.08 | 2.11 | (1.23) | 6.42 | |
| ATRC | AtriCure | (1.88) | 8 per month | 1.41 | 0.17 | 4.67 | (3.12) | 23.09 | |
| BDXB | Becton Dickinson And | (1.09) | 2 per month | 0.00 | (0.20) | 0.76 | (0.83) | 4.00 | |
| PDEX | Pro Dex | 1.09 | 11 per month | 4.33 | 0.21 | 9.99 | (9.00) | 28.08 | |
| ATRI | ATRION | (0.10) | 7 per month | 0.00 | (0.13) | 0.94 | (1.35) | 6.29 | |
| LMAT | LeMaitre Vascular | 5.62 | 8 per month | 1.23 | 0.11 | 3.15 | (2.19) | 10.31 |
Repro Med Additional Predictive Modules
Most predictive techniques to examine Repro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Repro using various technical indicators. When you analyze Repro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Repro Med Predictive Indicators
The successful prediction of Repro Med stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Repro Med Systems, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Repro Med based on analysis of Repro Med hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Repro Med's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Repro Med's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.002203 | 0.003082 | Price To Sales Ratio | 3.93 | 2.26 |
Story Coverage note for Repro Med
The number of cover stories for Repro Med depends on current market conditions and Repro Med's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Repro Med is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Repro Med's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Repro Med Short Properties
Repro Med's future price predictability will typically decrease when Repro Med's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Repro Med Systems often depends not only on the future outlook of the potential Repro Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repro Med's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 45.6 M | |
| Cash And Short Term Investments | 11.5 M |
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |